Skip to main content

Advertisement

Log in

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to establish the prevalence, severity, and correlates of psychological distress and impaired generic health-related quality of life (HRQOL) in testicular cancer (TC) survivors.

Methods

Men who had completed active anti-cancer treatment for TC between 6 months and 5 years previously showing no evidence of recurrence were recruited from 14 Australian cancer centers from September 2009 to February 2011. Participants completed a self-report questionnaire measuring demographic, disease, and treatment information, psychological distress (i.e., depression, anxiety, and stress; DASS21), generic health-related quality of life (HRQOL; SF-36v2), TC-specific HRQOL (EORTC QLQ-TC26), coping (MAC), social support (DUFSS), and unmet needs (CaSUN).

Results

Of 486 eligible TC survivors, 244 (50.2 %) completed the questionnaire. Compared with normative data, TC survivors reported: small but statistically significant increases in mean levels of anxiety and depression; a greater prevalence of moderate to extremely severe anxiety (19 %) and depression (20 %); and significant deficits to mostly mental aspects of generic HRQOL. The most problematic TC-specific HRQOL issues (e.g., fear of recurrence) were also more mental than physical. In multiple regression analyses, the strongest correlates of psychological distress and impaired generic HRQOL were psychosocial (e.g., helpless/hopeless coping and lower social support) rather than disease or treatment factors.

Conclusions

Generally, TC survivors appear to experience mild psychological distress and HRQOL impairments, while a vulnerable subgroup experience more severe morbidity.

Implications for Cancer Survivors

There is a need to identify TC survivors at risk of poorer outcomes and for interventions to target the areas of greatest impairment (i.e., psychological distress and mental HRQOL).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cancer Incidence in Five Continents. Lyon: IARC. 2007.

  2. Haugnes HS, Bosl GJ, Boer H, et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol. 2012;30:3752–63.

    Article  PubMed  Google Scholar 

  3. Fleer J, Hoekstra HJ, Sleijfer DT, et al. Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer. 2006;14:251–9.

    Article  CAS  PubMed  Google Scholar 

  4. Kim C, McGlynn KA, McCorkle R, et al. Quality of life among testicular cancer survivors: a case-control study in the United States. Qual Life Res: Int J Qual Life Asp Treat Care Rehabil. 2011;20:1629–37.

    Article  Google Scholar 

  5. Joly F, Heron JF, Kalusinski L, et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol. 2002;20:73–80.

    Article  CAS  PubMed  Google Scholar 

  6. Gudbergsson SB, Fosså SD, Dahl AA. Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study. Support Care Cancer. 2011;19:323–31.

    Article  PubMed  Google Scholar 

  7. Rossen PB, Pedersen AF, Zachariae R, et al. Health-related quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2009;27:5993–9.

    Article  PubMed  Google Scholar 

  8. Pedersen AD, Rossen P, Mehlsen MY, et al. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc. 2009;15:296–301.

    Article  CAS  PubMed  Google Scholar 

  9. Dahl AA, Haaland CF, Mykletun A, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:2389–95.

    Article  PubMed  Google Scholar 

  10. Skoogh J, Steineck G, Stierner U, et al. Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment. Acta Oncol. 2012;51:185–97.

    Article  CAS  PubMed  Google Scholar 

  11. Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003;21:1249–54.

    Article  PubMed  Google Scholar 

  12. Mykletun A, Dahl AA, Haaland CF, et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:3061–8.

    Article  PubMed  Google Scholar 

  13. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. J Am Med Assoc. 1995;273:59–65.

    Article  CAS  Google Scholar 

  14. Smith AB, King M, Butow P, Grimison P, Olver I. Reduced quality of life in internet-panel controls. Epidemiology. 2013;24:462–3.

    Article  Google Scholar 

  15. Smith AB, King M, Butow P, Olver I. A comparison of data quality and practicality of online versus postal questionnaires in a sample of testicular cancer survivors. Psychooncology. 2013;22:233–7.

    Article  PubMed  Google Scholar 

  16. Smith A, King M, Butow P, et al. The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psychooncology. 2013;22:2557–64.

    Article  PubMed  Google Scholar 

  17. Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. Secondth ed. Sydney: Psychology Foundation; 1995.

    Google Scholar 

  18. Ware Jr JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s manual for the SF-36v2 Health Survey. 2nd ed. Lincoln: Quality Metric Incorporated; 2007.

    Google Scholar 

  19. Holzner B, Efficace F, Basso U, et al. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res. 2013;22:369–78.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med. 1988;18:203–9.

    Article  CAS  PubMed  Google Scholar 

  21. Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988;26:709–23.

    Article  CAS  PubMed  Google Scholar 

  22. Hodgkinson K, Butow P, Hunt GE, et al. The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (Cancer Survivors’ Unmet Needs measure). Psychooncology. 2007;16:796–804.

    Article  CAS  PubMed  Google Scholar 

  23. Fayers PM, Curran D, Machin D. Incomplete quality of life data in randomized trials: missing items. Stat Med. 1998;17:679–96.

    Article  CAS  PubMed  Google Scholar 

  24. Hawthorne G, Osborne RH, Taylor A, Sansoni J. The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res. 2007;16:661–73.

    Article  PubMed  Google Scholar 

  25. Kutner MH, Nachtsheim C, Neter J. Applied linear regression models. McGraw-Hill/Irwin; 2004.

  26. AIHW. Cancer in Australia 2010: an overview. In: Cancer series. AIHW, Canberra. 2010. http://www.aihw.gov.au/publication-detail/?id=6442472459. Accessed 8 March 2013 2013.

  27. Kessler RC, Wai TC, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–27.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Cohen J. A power primer. Psychol Bull. 1992;112:155–9.

    Article  CAS  PubMed  Google Scholar 

  29. Fossa SD, Dahl AA. Short Form 36 and Hospital Anxiety and Depression Scale: a comparison based on patients with testicular cancer. J Psychosom Res. 2002;52:79–87.

    Article  CAS  PubMed  Google Scholar 

  30. Rutskij R, Gaarden T, Bremnes R, et al. A study of coping in long-term testicular cancer survivors. Psychol Health Med. 2010;15:146–58.

    Article  PubMed  Google Scholar 

  31. Johansson M, Rydén A, Finizia C. Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer—a longitudinal study. BMC Cancer. 2011;11.

  32. Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;1–23.

  33. Paterson C, Jones M, Rattray J, Lauder W. Exploring the relationship between coping, social support and health-related quality of life for prostate cancer survivors: a review of the literature. Eur J Oncol Nurs. 2013;17:750–9.

    Article  PubMed  Google Scholar 

  34. Jonker-Pool G, Van de Wiel HB, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer—review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav. 2001;30:55–74.

    Article  CAS  PubMed  Google Scholar 

  35. Steiner JF, Cavender TA, Nowels CT, et al. The impact of physical and psychosocial factors on work characteristics after cancer. Psychooncology. 2008;17:138–47.

    Article  PubMed  Google Scholar 

  36. Pedersen AF, Rossen P, Olesen F, Von Der Maase H, Vedsted P. Fear of recurrence and causal attributions in long-term survivors of testicular cancer. Psychooncology. 2012;21:1222–8.

    Article  PubMed  Google Scholar 

  37. Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 2009;18:580–8.

    Article  PubMed  Google Scholar 

  38. Lewis FM. The impact of cancer on the family: a critical analysis of the research literature. Patient Educ Couns. 1986;8:269–89.

    Article  Google Scholar 

  39. Fegg MJ, Gerl A, Vollmer TC, et al. Subjective quality of life and sexual functioning after germ-cell tumour therapy. Br J Cancer. 2003;89:2202–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kim C, McGlynn KA, McCorkle R, et al. Fertility among testicular cancer survivors: a case-control study in the US. J Cancer Survivorship. 2010;4:266–73.

    Article  Google Scholar 

  41. Greer S, Moorey S, Baruch JDR, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br Med J. 1992;304:675–80.

    Article  CAS  Google Scholar 

  42. Gottlied BH, Wachala ED. Cancer support groups: a critical review of empirical studies. Psychooncology. 2007;16:379–400.

    Article  Google Scholar 

  43. Rosenberg JP. Circles in the surf: Australian masculinity, mortality and grief. Crit Public Health. 2009;19:417–26.

    Article  Google Scholar 

  44. Griffiths KM, Farrer L, Christensen H. The efficacy of internet interventions for depression and anxiety disorders: a review of randomised controlled trials. Med J Aust. 2010;192:S4–11.

    PubMed  Google Scholar 

Download references

Acknowledgments

This study was co-funded by beyondblue and Cancer Australia (grant number 507961). Dr Allan “Ben” Smith was supported by an Australian Rotary Health Ian Scott Scholarship. Professor Butow holds a NHMRC Senior Principal Research Fellowship, and Professor King is supported by the Australian Government through Cancer Australia. The study was conducted by PoCoG in collaboration with ANZUP. The authors would like to thank all the men who participated in the study, as well as investigators and trials staff at the following hospitals: Border Medical Oncology, Canberra, Concord Repatriation General, Flinders Medical Centre, Liverpool, Princess Alexandra, Peter MacCallum Cancer Centre, Prince of Wales, Royal Adelaide, Royal North Shore, Royal Prince Alfred, St George, Tweed and Westmead.

Conflicts of interest

The authors declare that they have no competing interests.

Informed consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Allan “Ben” Smith.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 155 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, A.“., Butow, P., Olver, I. et al. The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study. J Cancer Surviv 10, 223–233 (2016). https://doi.org/10.1007/s11764-015-0468-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-015-0468-5

Keywords

Navigation